 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News FDA Grants Full Approval to J&J's HIV DrugDecember 8, 2009 Johnson & Johnson's Tibotec division has announced the Food and Drug Administration has granted full approval to its HIV drug Intelence. The twice-daily tablet, a non-nucleoside reverse transcriptase inhibitor that works by blocking an enzyme HIV needs to multiply, is already approved for use in 50 countries. Under its accelerated approval program, FDA in January 2008 gave its permission for the drug to be marketed in the United States. However, full approval was conditional upon follow-up data about the drug's effectiveness. These data showed that 60 percent of patients on Intelence for 48 weeks had attained undetectable HIV viral loads, compared to 38 percent of control patients. Intelence is intended for HIV patients who have stopped responding to other treatments. Associated Press 11.25.2009  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
